Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07060898 · ClinicalTrials.gov registry record · NA
Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes
A NA study of Aging and Cognitive Decline, sponsored by Amazentis.
- Active
- Registry status
- NA
- Development phase
- 650
- Enrollment target
- 1
- Study location
NCT07060898: Active NA study of Aging and Cognitive Decline, sponsored by Amazentis.
NCT07060898 is a NA study of Aging and Cognitive Decline that is active but no longer recruiting, run by Amazentis. The registered enrollment target is 650 participants, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07060898, a NA study of Aging and Cognitive Decline, is active but no longer recruiting, sponsored by Amazentis.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.
Primary Outcome
Change in cognitive function score as assessed by PROMIS Cognitive Function 8A (scale 8-40; where higher scores correspond to better cognitive function)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Active Product
- DIETARY_SUPPLEMENT Placebo Product
Study Locations (1)
California
- Radicle Science, Inc Office - Encinitas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2025-07-29 |
| Est. Completion | 2026-11-20 |
| Phase | NA |
What the registry record for NCT07060898 still lists
NCT07060898 is an interventional study that assigns participants to a tested intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap, below the 2,192-participant average among 262 other Aging trials with a reported enrollment target (70% lower).
The record links to 4 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Active Product is the first listed.
NCT07060898 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07060898 about?
NCT07060898 is a clinical study titled "Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes". This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placeb...
What is the current status of trial NCT07060898?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2025-07-29. Estimated completion is 2026-11-20.
What conditions does trial NCT07060898 study?
This clinical trial studies the following conditions: Aging, Cognitive Decline, Cognitive Function, Brain Fog.
What interventions are being tested in trial NCT07060898?
The interventions under investigation include: Active Product (DIETARY_SUPPLEMENT), Placebo Product (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07060898?
This trial is sponsored by Amazentis, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07060898 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07060898's enrollment target sits among peer trials
650 18th of 262 higher than 245 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
- NCT05046600 · 650 participants
Registry of Arthrex Hand and Wrist Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI